Clinical Trial Update: Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

View source ↗

Summary

A clinical trial update indicates a study evaluating chemotherapy combined with immunotherapy for HER2 insertion or amplification in advanced non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING